Baxter International (BAX)

R&D to Revenue

4.36%

Quarterly · Period ending:

BAX logo

BAX R&D to Revenue

Latest reported4.36%
BAX Quarterly R&D/Revenue (0.00% → 4.36%)
High-resolution chart · PNG

BAX r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Baxter International R&D to Revenue — Quarterly
Period endingR&D to Revenue
4.3581%
5.1462%
4.2367%
4.1623%
4.7687%
5.3333%
7.6644%
4.7795%
4.8255%
4.8193%
4.4273%
5.1174%
4.451%
4.6684%
3.9877%
4.184%
4.118%
4.0464%
3.9271%
3.9988%
4.4868%
4.3449%
4.2439%
4.1386%
4.3046%
5.2106%
5.1333%
5.0509%
5.8574%
4.8901%
6.1598%
6.0123%
6.1224%
5.2297%
6.5609%
5.5412%
5.9501%
5.1313%
5.9357%
6.2158%
7.5435%
5.7263%
6.1852%
5.9509%
6.101%
5.9509%
7.4911%
5.5002%
7.7516%
8.0301%
10.0046%
7.4663%
7.4407%
7.1346%
7.7538%
8.3405%
8.5666%
7.9398%
7.0673%
6.8698%
6.759%
6.5164%
7.49%
6.4206%
6.8566%
7.7554%
7.0893%
7.2496%
7.3967%
7.5071%
7.2181%
7.2993%
6.9614%
6.6041%
7.3446%
7.3818%
6.2566%
5.9439%
6.5509%
5.8271%
5.5115%
5.7285%
5.3794%
5.5463%
5.161%
5.5812%
4.9212%
5.3448%
5.4224%
6.1566%
5.5577%
6.174%
6.4292%
6.8102%
6.9253%
5.804%
6.0831%
6.1333%
5.3839%
5.5263%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.